WebSep 1, 2024 · According to the 9 th edition of the IDF Atlas of Diabetes published in 2024, diabetes has developed into a global pandemic non-communicable epidemic, with 90% of people with diabetes having T2D ... WebLogistic regression was used to generate smoothed age-specific diabetes prevalence estimates (including previously undiagnosed diabetes) in adults aged 20–79 years. Results: The global diabetes prevalence in 2024 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045.
4th edition IDF Diabetes Atlas
WebNov 1, 2024 · The 2024 Diabetes Atlas delineated both accomplishments and challenges in diabetes care in Taiwan between 2005 and 2014. The series reported that Taiwan had significantly improved aspects of care quality for patients with diabetes. For example, the mortality rate decreased, the difference between the life expectancies of patients with … WebAim: Hyperglycaemia in pregnancy (HIP) is one of the most common complications of pregnancy. This study aims to examine the projected HIP prevalence in 2030 and 2045 using multiple methods. Methods: The International Diabetes Federation Diabetes Atlas 2024 prevalence was projected to 2030 and 2045 by: (1) carrying forward the 2024 age … flight ws336
Resources and tools - IDF
WebIDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2024 ... Results: The global prevalence of DR and DME, for the period 2015 to 2024 were 27.0% for any DR comprising of 25.2%, NPDR, 1.4% PDR and 4.6% DME. The lowest prevalence was in Europe at … WebThe latest Atlas reports that the global prevalence of diabetes has reached 9.3%, with more than half (50.1%) of adults undiagnosed. Type 2 diabetes accounts for about 90% of all people with diabetes. Key findings include in the Diabetes Atlas 2024: • One in 11 adults live with diabetes. • In 2024, it is estimated that 463 million people ... WebThe IDF Diabetes Atlas is an authoritative source of evidence on the prevalence of diabetes, related morbidity and mortality, as well as diabetes-related health expenditures at global, regional and national levels. ... Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Diabetes Res Clin Pract. 2024 Nov; 157:107843 ... flight ws3436